Cathay Biotech Inc. (SHA:688065)
47.74
+1.19 (2.56%)
Apr 29, 2026, 3:00 PM CST
Cathay Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 33,547 | 35,889 | 22,555 | 32,012 | 35,749 | 76,786 | Upgrade
|
| Market Cap Growth | 14.68% | 59.12% | -29.54% | -10.45% | -53.44% | 116.67% | Upgrade
|
| Enterprise Value | 28,413 | 30,779 | 22,818 | 31,823 | 33,878 | 71,142 | Upgrade
|
| Last Close Price | 46.55 | 49.80 | 38.48 | 54.26 | 60.32 | 128.99 | Upgrade
|
| PE Ratio | 56.77 | 64.01 | 46.13 | 87.34 | 64.61 | 129.11 | Upgrade
|
| Forward PE | 39.45 | 29.61 | 29.61 | 46.74 | 89.61 | 89.61 | Upgrade
|
| PS Ratio | 10.18 | 10.89 | 7.63 | 15.14 | 14.65 | 32.49 | Upgrade
|
| PB Ratio | 1.57 | 1.68 | 1.49 | 2.17 | 2.38 | 5.23 | Upgrade
|
| P/TBV Ratio | 1.98 | 2.12 | 2.08 | 3.06 | 3.52 | 7.77 | Upgrade
|
| P/OCF Ratio | 83.01 | 88.81 | 27.48 | 56.22 | 44.48 | 132.69 | Upgrade
|
| EV/Sales Ratio | 8.62 | 9.34 | 7.71 | 15.05 | 13.88 | 30.10 | Upgrade
|
| EV/EBITDA Ratio | 28.71 | 31.10 | 33.56 | 70.52 | 50.43 | 106.53 | Upgrade
|
| EV/EBIT Ratio | 42.14 | 45.65 | 62.70 | 192.23 | 83.32 | 142.50 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.13 | 0.12 | 0.08 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.51 | 0.51 | 2.79 | 3.94 | 1.68 | 1.11 | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.41 | -0.23 | -0.24 | -0.34 | -0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.84 | -8.84 | -5.07 | -8.01 | -7.69 | -13.31 | Upgrade
|
| Net Debt / FCF Ratio | 25.78 | 25.78 | 154.13 | 3.61 | 1.52 | 10.09 | Upgrade
|
| Asset Turnover | 0.15 | 0.15 | 0.16 | 0.12 | 0.14 | 0.17 | Upgrade
|
| Inventory Turnover | 1.65 | 1.65 | 1.60 | 1.01 | 1.17 | 1.56 | Upgrade
|
| Quick Ratio | 4.87 | 4.87 | 1.99 | 1.70 | 4.75 | 8.14 | Upgrade
|
| Current Ratio | 5.85 | 5.85 | 2.53 | 2.22 | 5.95 | 9.36 | Upgrade
|
| Return on Equity (ROE) | 2.91% | 2.91% | 3.18% | 2.74% | 4.12% | 4.84% | Upgrade
|
| Return on Assets (ROA) | 1.96% | 1.96% | 1.20% | 0.56% | 1.49% | 2.20% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.52% | 4.68% | 2.76% | 1.43% | 4.57% | 7.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.10% | 3.10% | 2.30% | 1.10% | 2.50% | 3.30% | Upgrade
|
| Earnings Yield | 1.67% | 1.56% | 2.17% | 1.15% | 1.55% | 0.78% | Upgrade
|
| FCF Yield | -1.01% | -0.95% | -0.10% | -3.13% | -9.50% | -1.15% | Upgrade
|
| Dividend Yield | 0.85% | - | 1.04% | 0.35% | 0.30% | 0.25% | Upgrade
|
| Payout Ratio | 55.84% | 55.84% | 28.80% | 37.58% | 37.39% | 57.11% | Upgrade
|
| Buyback Yield / Dilution | -17.47% | -17.47% | -0.05% | 0.10% | 0.11% | -7.38% | Upgrade
|
| Total Shareholder Return | -16.62% | -17.47% | 0.99% | 0.45% | 0.41% | -7.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.